Abbott Labs (ABT) free cash flow was $7.4B in FY2025 (+16% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$7.4B
+16%
2024
$6.4B
+26%
2023
$5.1B
-35%
2022
$7.8B
-10%
2021
$8.6B
+51%
2020
$5.7B
+27%
2019
$4.5B
-8%
2018
$4.9B
+11%
2017
$4.4B
+113%
2016
$2.1B
+12%
2015
$1.9B
-29%
2014
$2.6B
+19%
2013
$2.2B
-71%
2012
$7.5B
+1%
2011
$7.5B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q1 2026
$916M
Q4 2025
$2.6B
Q3 2025
$2.3B
Q2 2025
$1.5B
Q1 2025
$933M
Q4 2024
$2.1B
Q3 2024
$2.1B
Q2 2024
$1.4B
Q1 2024
$627M
Q4 2023
$2.3B
Q3 2023
$1.3B
Q2 2023
$696M
Source: ABT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.